Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Oct
13
2026
 More Than Research? Why the Coming Federal Definition of Ultra-Processed Foods Matters Greenberg Traurig, LLP
Oct
13
2026
 FDA Issues Final Rule on Salt Substitutes in Standardized Foods Keller and Heckman LLP
Oct
13
2026
 Company Sued Over ‘Sugar-Free’ Beverages Due to Sugar from Lactose Keller and Heckman LLP
Oct
13
2026
 Draft Citizen Petition Requests Warning on Raw-Milk Cheese Keller and Heckman LLP
Oct
13
2026
 FDA Launches Nationwide Recruitment Effort for Advisory Committees Keller and Heckman LLP
Oct
13
2026
 FDA Releases 2025 CORE-EP Annual Report Keller and Heckman LLP
Oct
8
2026
 Marijuana Rescheduling Temporarily Paused Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Oct
8
2026
 New Biosimilar Legislation Addresses Inflation Reduction Act Delay Provision Polsinelli PC
Oct
8
2026
 EPA Announces the Availability of the Final 4-CPA Registration Review Decision before the Registration Review Deadline Bergeson & Campbell, P.C.
Oct
8
2026
 The Medical Device Launch Playbook: Patents, FDA, Reimbursement and Strategic Timing Polsinelli PC
Oct
7
2026
 Proposed H.R. 10336 Would Balance Innovation, Access to Dietary Supplements—Yet Change the Definition Epstein Becker & Green, P.C.
Oct
7
2026
 This Week in 340B: September 29 – October 5, 2026 McDermott Will & Schulte LLP
Oct
7
2026
 Preemption Protections and Next Steps: What Retailers Need to Know About the Durnell Decision Hunton Andrews Kurth
Oct
7
2026
 Beyond Animal Testing: FDA's 2026 Framework for Fit-for-Purpose NAMs Foley & Lardner LLP
Oct
7
2026
 From State Regulation to Federal Rescheduling: Lessons Learned and the Road Ahead Blank Rome LLP
Oct
7
2026
 340B Rebate Pilot — The Clock Starts Now Mintz
Oct
6
2026
 Compliance with Bilingual Labeling Requirements for Antimicrobial and Non-Agricultural Products with Acute Toxicity Category I Is December 29, 2026 Bergeson & Campbell, P.C.
Oct
6
2026
 And/Or Else- “And/Or” Renders a Communicable Disease Exclusion Ambiguous Hunton Andrews Kurth
Oct
5
2026
 EUON Study Identifies Knowledge Gaps on Nanomaterials Used in Flame Retardants Bergeson & Campbell, P.C.
Oct
5
2026
 States Further Legislation to Restrict Sale of Weight Loss, Muscle Building Products to Minors Epstein Becker & Green, P.C.
Oct
5
2026
 Banning Corporate Medicine: The Costs Congress Isn't Pricing In Mintz
Oct
5
2026
 Governor Newsom Signs Bill for Non-UPF Certification Program Keller and Heckman LLP
Oct
5
2026
 Lawmakers Demand Answers from USDA on Halting of Cyclospora Research Keller and Heckman LLP
Oct
1
2026
 Federal Court Affirms Arbitrator's Reinstatement of Worker After Positive Drug Test Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Oct
1
2026
 Delaware Court Extends Hikma to Labels Without Carve-Outs Polsinelli PC
Oct
1
2026
 Registration Is Open for DOE’s Agile BioFoundry’s Industry Day on October 26, 2026 Bergeson & Campbell, P.C.
Oct
1
2026
 Indonesia’s New Food Packaging Regulation: Key Compliance Changes Keller and Heckman LLP
Sep
30
2026
 Hurry Up and Wait—DEA’s Rescheduling Hearing Hits the Brakes Over Its Own Alleged Process Gaps Bradley Arant Boult Cummings LLP
Displaying 1 - 28 of 13475
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters